This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
TheResearchPost
  • Menu
  • Articles
    • Original Research
    • All
  • For Authors
  • Editorial Board
  • About
  • FAQs
  • Blog
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

https://theresearchpost.scholasticahq.com/feed
Original Research
December 16, 2022 EDT

Clinical Remission With Biologic Use Among US Subspecialist-Treated Patients With Severe Asthma: Results From the CHRONICLE Study

Bradley E Chipps, MD, Njira Lugogo, MD, Warner Carr, MD, Eduardo Genofre, MD, Frank Trudo, MD, Christopher S Ambrose, MD,
severe asthmabiologicsasthma remission
Copyright Logoccby-nc-nd-4.0 • https://doi.org/10.53705/22121601
TheResearchPost
1.
Chipps BE, Lugogo N, Carr W, Genofre E, Trudo F, Ambrose CS. Clinical Remission With Biologic Use Among US Subspecialist-Treated Patients With Severe Asthma: Results From the CHRONICLE Study. TheResearchPost. 2022;1. doi:10.53705/​22121601

View more stats

Powered by Scholastica, the modern academic journal management system